Control of cervical cancer: Women's options and rights

International Journal of Gynecology and Obstetrics

Volumn 106, Issue 2, 2009, Pages 141-143

  Cain, Joanna M ^a   Ngan, Hextan ^b   Garland, Suzanne ^c   Wright, Thomas ^d  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c Royal Womens Hospital   (Australia)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Cervical cancer control; Women's rights

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER PREVENTION; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; DEVELOPING COUNTRY; FEMALE; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH EDUCATION; HUMAN; HYSTERECTOMY; PRIORITY JOURNAL; RIGHT TO LIFE; UTERINE CERVIX CANCER; WOMEN'S HEALTH; WOMEN'S RIGHTS;

EID: 67650253834     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2009.03.027     Document Type: Article

References (12)

1. World Health Organization. Comprehensive Cancer Control: a guide to essential practice (2006), WHO, Geneva
2. Chan J.K., and Berek J.S. Impact of the human papilloma vaccine on cervical cancer. J Clin Oncol 25 20 (2007) 2975-2982
3. Howett M.K., and Kuhl J.P. Microbicides for prevention of transmission of sexually transmitted diseases. Curr Pharm Des 11 29 (2005) 3731-3746
4. Agosti J.M., and Goldie S.J. Introducing HPV vaccine in developing countries--key challenges and issues. N Engl J Med 356 19 (2007) 1908-1910
5. Garland S.M., Brotherton J.M., Skinner S.R., Pitts R., Saville M., Mola G., et al. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention. Vaccine 26 Suppl 12 (2008) M80-M88
6. Garland S.M., Hernandez-Avila M., Wheeler C.M., Perez G., Harper D.M., Leodolter S., et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 356 19 (2007) 1928-1943
7. Wright T.C., Bosch F.X., Franco E.L., Cuzick J., Schiller J.T., Garnett G.P., et al. Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts. Vaccine 24 Suppl 3 (2006) S3/251-61
8. Goel A., Gandhi G., Batra S., Bhambhani S., Zutshi V., and Schachdeva P. Visual inspection of the cervix with acetic acid for cervical intraepithelial lesions. Int J Gynecol Obstet 88 1 (2005) 25-30
9. Claeys P., De Vuyst H., Gonzalez C., Garcia A., Bello R.E., and Temmeramn M. Performance of the acetic acid test when used in field conditions as a screening test for cervical cancer. Trop Med Int Health 8 8 (2003) 704-709
10. Pecorelli S., Ngan H., and Hacker N.F. Staging classifications and clinical practice guidelines gynaecological cancers (2006), FIGO, London 37-60. http://www.figo.org/docs/staging_booklet.pdf Available at: http://www.figo.org/docs/staging_booklet.pdf
11. Garland S., Park S.N., Ngan H.Y., Frazer I., Tay E.H., Chen C.J., et al. The need for public education on HPV and cervical cancer prevention in Asia. Opinions of experts at the AOGIN Conference. Vaccine 26 43 (2008) 5435-5440
12. Hunt P, Bueno de Mesquita J. The Rights to Sexual and Reproductive Health. Human Rights Centre. University of Essex. Available at: http://www2.essex.ac.uk/human_rights_centre/rth/docs/TheRightsToSexualHealth.pdf. Accessed January 11, 2008.